APS (Acta Pharmacologica Sinica) [ISSN 1671-4083 (Print), 1745-7254 (Online)] is the official journal of the Chinese Pharmacological Society, publishing high-quality original research articles, reviews and editorials on all aspects of the field of pharmacology and related life sciences.

The editorial team is led by Jian Ding, Editor-in-Chief, and includes a highly respected international editorial board. Together, the editorial team of APS and Nature Publishing Group look to further define and shape the field of pharmacology.

APS will be an integral part of international pharmacological research by encouraging and publishing original research articles that report findings of wide biological significance in the multidisciplinary field of pharmacology and related life sciences. APS will provide a dynamic platform for communicating research in this field through also including insightful and up-to-date reviews and letters to the editor.

Impact factor

2009 impact factor 1.783*
48/138 in Chemistry, Multidisciplinary
152/236 in Pharmacology & Pharmacy
*Journal Citation Reports, Thomson 2010

Abstracted/indexed in

BIOSIS, CA, CSA Medical Biotechnology, CSA Bioengineering, CSA Neuroscience, Current Contents/Life Sciences, Excerpta Medica, FSTA, Global Health, IndexCopernicus, Index Medicus, Kagaku Gijutsu Bunken Sokuho (Japan), MEDLINE, VINITI (Russia), Research Alert, Science Citation Index, SciSearch, Scopus, and Tropical Diseases Bulletin, among others.

Aims and Scope

APS encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

URL :http://www.chinaphar.com/